Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |